Abacus Life, Inc. (ABL) Expected to Beat Earnings Estimates: Should You Buy?

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Abacus Life, Inc. (ABL) despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Abacus Life, Inc. is expected to report quarterly earnings of $0.16 per share, reflecting an 11.1% decrease year-over-year [3]. - Revenue projections stand at $42.26 million, indicating a significant increase of 45.3% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.69% higher in the last 30 days, suggesting a positive reassessment by analysts [4]. - The Most Accurate Estimate for Abacus Life is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.54% [12]. Earnings Surprise Prediction - A positive Earnings ESP reading indicates a higher likelihood of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Abacus Life has a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a strong possibility of exceeding the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Abacus Life was expected to earn $0.16 per share but achieved $0.18, resulting in a surprise of +12.50% [13]. - The company has successfully beaten consensus EPS estimates in all of the last four quarters [14]. Industry Comparison - F&G Annuities & Life, Inc. is another player in the life insurance sector, expected to report earnings of $0.64 per share, reflecting a year-over-year decline of 41.8% [18]. - F&G's revenue is projected at $1.18 billion, showing a slight increase of 0.9% from the previous year [18]. - The consensus EPS estimate for F&G has been revised 3.7% higher, but with an Earnings ESP of 0% and a Zacks Rank of 4, predicting an earnings beat is challenging [19].